Alyeska Investment Group, L.P. Pliant Therapeutics, Inc. Transaction History

Alyeska Investment Group, L.P.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2020 Nov 16, 2020	SELL	$21.54 - $29.53 $1.08 Million - $1.48 Million	-50,000 Reduced 70.86%	20,560 $465,000
Q2 2020 Aug 14, 2020	BUY	$21.3 - $35.26 $1.5 Million - $2.49 Million	70,560 New	70,560 $2.29 Million

168

63.2M

245K

373K

Ticker PLRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,682,000
Market Cap $600M
Description
Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...

Get notified when there are updates to the investment portfolio of Alyeska Investment Group, L.P., based on Form 13F filings with the SEC.

Stay updated on Alyeska Investment Group, L.P. with notifications on news.